John Farah
Fortune : 446 $ au 31/05/2026
Fortune : 446 $ au 31/05/2026
John Mitchell Farah is currently Director at Pond Technologies Holdings, Inc. since 2021.
Formerly, Dr. Farah was Independent Director at Rebus Holdings, Inc. from 2008 to 2010, Independent Director at Aeolus Pharmaceuticals, Inc. from 2011 to 2018, VP-International Pharmaceutical Operations at Cephalon LLC from 1992 to 2011, Chief Business Officer at Melior Discovery, Inc., and Discovery Research Scientist at G.D.
Searle & Co., Inc. Education includes undergraduate studies at New College of California and the University of Maryland, and a doctorate from the Uniformed Services University of the Health Sciences conferred in 1985.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2025 | 63 782 ( 0,07 % ) | 446 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| POND TECHNOLOGIES HOLDINGS INC. | Directeur/Membre du Conseil | 14/07/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/03/2018 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
| INSPYR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/08/2010 |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Provides in-vivo pharmacology services | Directeur/Membre du Conseil | 16/01/2013 |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Provides in-vivo pharmacology services | Commercial Services |
Rebus Holdings, Inc.
Rebus Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of novel targeted precision therapeutics | Health Technology |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Process Industries |
Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
New College of California
New College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uniformed Services University of the Health Sciences
Uniformed Services University of the Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pond Technologies Holdings, Inc.
Pond Technologies Holdings, Inc. Pharmaceuticals: OtherHealth Technology Engages in production and sale of nutraceutical and related products to business and retail customers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national